Latest Breaking News On - Seana mccarthy - Page 4 : comparemela.com

CytomX Therapeutics : 2023 Annual Report -April 08, 2024 at 04:04 pm EDT

2 0 2 3 A n n u a l R e p o r t Dear Fellow CytomX Stockholders, Our vision at CytomX is to transform the.

Sean A. Mccarthy Sells 20,223 Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX) Stock

CytomX Therapeutics, Inc. (NASDAQ:CTMX) CEO Sean A. Mccarthy Sells 13,551 Shares

CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) CEO Sean A. Mccarthy sold 13,551 shares of the business’s stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $1.38, for a total value of $18,700.38. Following the completion of the sale, the chief executive officer now […]

CytomX Therapeutics, inc (CTMX) Q2 2021 Earnings Call Transcript

CytomX Therapeutics, Inc. (CTMX) Q1 2021 Earnings Call Transcript

Operator Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the CytomX Therapeutics First Quarter 2021 Financial Results Call. Please be advised that today s call is being recorded. I would now like to hand the conference over to your host for today, Chau Cheng, CytomX Vice President, Investor Relations and Corporate Communications. Please go ahead. Chau Cheng Vice President, Investor Relations and Corporate Communications Thank you, Susan. Good afternoon, and thank you for joining us. With me today are Dr. Sean McCarthy, CytomX s President, Chief Executive Officer and Chairman; and Carlos Campoy, Chief Financial Officer. Earlier today, we issued a press release that includes a summary of our first quarter 2021 financial results and highlights the important progress we made during the quarter. We encourage everyone to read today s press release and the associated materials, which have been filed with the SEC. Additionally, the press release and the rec